Hank Green 11 days ago
This is very, very interesting but not proof of effect. They looked at a large group of people with diabetes, some taking GLP-1s, some taking DPP-4 inhibitors. The ones who had cancer and were taking GLP-1s, on average, had significantly better outcomes than a matched group on DPP-4 inhibitors.
add a skeleton here at some point
